【短篇論著】褚建國:門靜脈壓力梯度預測TIPS術後高危人群肝性腦病的研究

[1] Dhanasekaran R, West JK, Gonzales PC, et al. Transjugular

intrahepaticportosystemic shunt for symptomatic refractory hepatic

hydrothoraxin patients with cirrhosis[J]. Am J Gastroenterol, 2010,

105(3): 635-641. DOI: 10.1038/ajg.2009.634.

[2] Qi X, Guo W, He C, et al. Transjugular intrahepatic portosystemic

shuntfor Budd-Chiari syndrome: techniques, indications and results

on 51 Chinese patients from a single centre[J]. Liver Int, 2014, 34(8):

1164-1175. DOI: 10.1111/liv.12355.

[3] Kikolski SG, Aryafar H, Rose SC, et al. Transjugular intrahepatic

portosystemic shunt for treatment of cirrhosis-related chylothorax

and chylous ascites: single-institution retrospective experience[J].

Cardiovasc Intervent Radiol, 2013, 36(4): 992-997. DOI: 10.1007/

s00270-012-0530-x.

[4] Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic

shunt for portal vein thrombosis with symptomatic portal hypertension

in liver cirrhosis[J]. J Hepatol, 2011, 54(1): 78-88. DOI: 10.1016/

j.jhep.2010.06.029.

[5] Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in

patients with cirrhosis and variceal bleeding[J]. N Engl J Med, 2010,

362(25): 2370-2379. DOI: 10.1056/NEJMoa0910102.

[6] Boyer TD, Haskal ZJ; American Association for the Study of Liver

Diseases. The role of transjugular intrahepatic portosystemic shunt

(TIPS) in the management of portal hypertension: update 2009[J].

Hepatology, 2010, 51: 306. DOI: 10.1002/ /hep.23383.

[7] Bai M, Qi X, Yang Z, et al. Predictors of hepatic encephalopathy after

transjugular intrahepatic portosystemic shunt in cirrhotic patients: a

systematic review[J]. J Gastroenterol Hepatol, 2011, 26(6): 943-951.

DOI: 10.1111/j.1440-1746.2011.06663.x.

[8] Lee JY, Kim TY, Jeong WK, et a1.Clinically severe portal

hypertension: role of multidetector row CT features in diagnosis[J].

Dig Dis Sci, 2014, 59(9): 2333-2343. DOI: 10.1007/s10620-014-

3149-8.

[9] Zeng DB, Dai CZ, Lu SC, et a1.Abnormal splenic artery diameter/

hepatic artery diameter ratio in cirrhosis—induced portal

hypertension[J]. World J Gastroenterol, 2013, 19(8): 1292-1298. DOI:

10.3748/wjg.v19.i8.1292.

[10] Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs.uncovered

stents for transjugular intrahepatic portosystemic shunt: a randomized

controlled trial[J]. J Hepatol, 2014, 60(5): 962–968. DOI: 10.1016/

j.jhep.2014.01.015.

[11] Lv Y, Yang LP, Liu L, et al. Early TIPS with covered stents

versus standard treatment for acute variceal bleeding in patients

with advanced cirrhosis: a randomised controlled trial[J]. Lancet

Gastroenterol Hepatol, 2019. DOI: 10.1016/S2468-1253(19)30090-1.

[12] 蔡煒 , 諸葛宇徵 , 張建武 , 等 . 不同支架經頸靜脈肝內門體靜

脈分流術治療肝硬化食管胃靜脈曲張出血的安全性和療效研

究 [J]. 中華肝臟病雜誌 , 2015, 23(4): 258-264. DOI: 10.3760/cma.

j.issn.1007-3418.2015.04.006.

[13] Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic

encephalopathy[J]. N Engl J Med, 2010, 362: 1071-1081. DOI:

10.1056/NEJMc1004719 .

[14] 劉滿華 , 周峰 , 王曉兵 , 等 .116 例經頸靜脈肝內門體靜脈分

流術治療肝硬化門靜脈高壓症的隨訪研究 [J]. 中華肝臟病雜

志 , 2018, 26(8): 596-600. DOI: 10.3760/cma.j.issn.1007-3418.2018.

08.007.

[15] Rössle M. TIPS: 25 years later[J]. J Hepatol, 2013, 59(5): 1081-1093.

DOI: 10106 /j.jhep.2013.06.014.

[16] Zipprich A, Garcia TG, Rogowski S, et a1.Prognostic indicators

of survival In patients with compensated and de-compensated

cirrhosis[J]. Liver Int, 2012, 32(19): 1407-1414. DOI: 10.1111/j.1478-

3231.2012.02830.x.

[17] Xue H, Zhang M, Pang JX, et a1. Transjugular intrahepatic

portosystemic shunt vs endoscopic therapy in preventing variceal

rebleeding[J]. World J Gastroenterol, 2012, 18（48): 7341-7347. DOI:

10.3748/wjg.v18.i48.7341.

[18] He FL, Wang L, Yue ZD, et a1. Parallel transjugular intrahepatic

portosystemic shunt for controlling portal hypertension complications

in cirrhotic patients[J]. World J Gastroenterol, 2014, 20(33): 11835-

11839. DOI: 10.3748/wjg.v20.i33.11835.